Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Select your origin of interest
The recent findings and the current understanding of fatty acid oxidation and CPT1A in cancer have been summarized thus providing theoretical basis for this enzyme as an emerging potential molecular target in cancer therapeutic intervention. (Review)
Methylation of a CpG site in CPT1A is associated with circulating adiponectin (show ADIPOQ Proteins) levels, likely in an obesity-dependent manner, in three population-based adult cohorts of European descent.
Furthermore, given the already low abundance of Cpt1b (show CPT1B Proteins) in white adipose tissue, it is unlikely that decreases in its expression can quantitatively decrease whole body energy expenditure enough to contribute to an obese phenotype.
Data show that in the absence of indoleamine 2,3-dioxygenase (IDO (show IDO1 Proteins)) inhibition, fatty acid oxidation increased along with increased activity of carnitine palmitoyltransferase I (CPT1).
our results proved CPT1A as a potential prognosticator and therapeutic target for AML (show RUNX1 Proteins).
High CPT1A expression is associated with ovarian cancer.
Methylation at 2 CpG sites in CPT1A on chromosome 11 was significantly associated with MetS. Significant associations were replicated in both European and African ancestry participants.
CPT1 is active on the outer surface of mitochondria and serves as a regulatory site for fatty acid oxidation due to its sensitivity for malonyl-CoA. CPT1a is the hepatic isoform.
the structure of the regulatory domain of CPT1C (show CPT1C Proteins) was determined (residues Met1 (show GZMM Proteins)-Phe50) by NMR spectroscopy.
Targeting the leukemia cell metabolism by the CPT1a inhibition
acetate is the primary product of hepatic mitochondrial beta-oxidation in Sus scrofa and that regulation during early development is mediated primarily via kinetic modulation of CPT I (show CPT1B Proteins)
This study evaluated the effects of nonesterified fatty acids and glucose on carnitine palmitoyltransferase-I (CPT-I) mRNA expression in cultured bovine hepatocytes using real-time reverse transcription polymerase chain reaction and ELISA methods.
It was conclude that suppression of CPT (show DHDDS Proteins) activity by positive energy balance appears to be specific for the liver in mid-lactating dairy cows.
beneficial effects of muscle CPT1mt expression suggest that a direct modulation of the malonyl-CoA/CPT1 partnership in skeletal muscle could represent a potential strategy to prevent obesity-induced insulin (show INS Proteins) resistance
The data suggest that AMPK (show PRKAA1 Proteins) is not required for the regulation of the intermediate filament interaction with CPT-I during exercise.
these results demonstrated that L-carnitine ameliorated liver inflammation and serum pro-inflammatory markers in cancer cachexia through regulating CPT I-dependent PPARg (show PPARG Proteins) signaling
-Carnitine exerts its ameliorative effects in cancer cachexia in association with the PPAR-gamma (show PPARG Proteins) signaling pathway.
Data show that peroxisome-proliferator-activated receptor beta (show PPARD Proteins)/delta (PPARbeta (show PPARD Proteins)/delta) activation restored the lipid-induced endothelial dysfunction by up-regulation of carnitine palmitoyltransferase)-1 (CPT-1).
Our results indicated that exercise-induced CPT1b (show CPT1B Proteins) expression was at least in part mediated by HDAC5 (show HDAC5 Proteins)/MEF2A (show MEF2A Proteins) interaction.
an environment-dependent structural switch underlies the regulation of carnitine palmitoyltransferase 1A
miR (show MLXIP Proteins)-370 acting via miR (show MLXIP Proteins)-122 may have a causative role in the accumulation of hepatic triglycerides by modulating initially the expression of SREBP-1c (show SREBF1 Proteins), DGAT2 (show DGAT2 Proteins), and Cpt1alpha.
Results show that CREB and HNF4alpha bind the CPT promoter, that PGC-1 is involved in liver carnitine palmitoyltransferase I (CPT) gene activation by cylic AMP, and that PGC-1 acts to coordinate the process of metabolic adaptation in the liver.
The mitochondrial oxidation of long-chain fatty acids is initiated by the sequential action of carnitine palmitoyltransferase I (which is located in the outer membrane and is detergent-labile) and carnitine palmitoyltransferase II (which is located in the inner membrane and is detergent-stable), together with a carnitine-acylcarnitine translocase. CPT I is the key enzyme in the carnitine-dependent transport across the mitochondrial inner membrane and its deficiency results in a decreased rate of fatty acid beta-oxidation. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
carnitine palmitoyltransferase 1A (liver)
, carnitine O-palmitoyltransferase 1, liver isoform-like
, CPT I
, carnitine O-palmitoyltransferase 1, liver isoform
, carnitine O-palmitoyltransferase I, liver isoform
, carnitine palmitoyltransferase I, liver
, carnitine palmitoyl transferase I liver isoform
, liver type carnitine palmitoyltransferase I
, mitochondrial carnitine palmitoyltransferase 1A
, carnitine palmitoyltransferase 1A
, carnitine palmitoyltransferase I
, carnitine palmitoyl transferase I isoform
, L-CPT I
, carnitine palmitoyltransferase 1, liver
, Carnitine palmitoyltransferase 1 alpha, liver isoform